How i treat cancer-associated venous thromboembolism

48Citations
Citations of this article
158Readers
Mendeley users who have this article in their library.

Abstract

Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism, is a common complication of cancer and is associated with significant morbidity and mortality. Several cancer-related risk factors contribute to the development of VTE including cancer type and stage, chemotherapy, surgery, and patient-related factors such as advanced age and immobilization. Patients with cancer frequently undergo diagnostic imaging scans for cancer staging and treatment response evaluation, which is increasing the underlying risk of VTE detection. The management of cancer-associated VTE is challenging. Over the years, important advances have been made and, recently, randomized controlled trials have been published helping clinicians' management of this patient population. In this review, we will discuss common cancer-associated VTE scenarios and critically review available evidence to guide treatment decisions.

Cite

CITATION STYLE

APA

Kraaijpoel, N., & Carrier, M. (2019). How i treat cancer-associated venous thromboembolism. Blood, 133(4), 291–298. https://doi.org/10.1182/blood-2018-08-835595

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free